Sheldon Goldstein, M.D., Founder & CEO
Dr. Goldstein is the inventor of the MCTS™ device and the visionary behind the Company’s blood transfusion related Intellectual Property. Dr. Goldstein is an Internist & Cardiac Anesthesiologist practicing at Montefiore Medical Center, having received his medical degree at Hahnemann Medical College in Philadelphia (renamed Drexel/Hahnemann). Dr. Goldstein is an expert in the management of bleeding patients, and has been invited to speak on coagulation and transfusion topics on multiple occasions.
Michael Kagan, Director of Product Development
Mr. Kagan leads the development process for the Company’s devices, from prototyping and testing to manufacturing transfer and commercialization. Mr. Kagan brings 28 years of successful experience in the diagnostics industry, having worked at Immunicon, Siemens HealthCare, and Ciba Corning, where he led engineering and manufacturing initiatives that resulted in FDA clearances for six in-vitro medical devices, and the test kits that operate on these platforms.
Sheldon Freedman, Director of Investor Relations and Counsel
Mr. Freedman guides the Company’s capital raising strategy and acts as in-house counsel. Mr. Freedman brings 25 years of experience as a business lawyer, venture capitalist and investment banker. He is a former partner in 21 Ventures LLC, a New York venture capital firm with a portfolio of 37 early-stage technology companies worldwide. Mr. Freedman is a guest lecturer at the New York Academy of Sciences on the subject of commercialization of technology. Mr. Freedman holds a degree in Economics from the University of Toronto and a Law degree from the University of Windsor.